相关实验视频
Updated: Feb 10, 2026

07:16
Minimum Volume Vitrification of Immature Feline Oocytes
Published on: June 24, 2020
7.0K
工程VP1 mRNA疫苗诱导免疫力和对猫猫病毒的完整保护
Meng-Di Zhang1,2, Zhuo-Fang Xie1,2, Xin-Hong Li1,2
1Guangdong Laboratory for Lingnan Modern Agriculture, College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, Guangdong, China, scau.edu.cn.
Transboundary and emerging diseases
|February 9, 2026
概括
一种使用VP1蛋白的新型信使RNA (mRNA) 疫苗,针对猫状病毒 (FCV),在猫身上显示出完全的保护作用. 这种FCV疫苗为预防猫呼吸道疾病的传统方法提供了一个有希望的替代方案.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 猫病毒 (FCV) 是猫上呼吸道感染的主要原因.
- 传统疫苗存在,但信使RNA (mRNA) 疫苗提供了快速开发和成本效益等优势.
- 开发有效的FCV疫苗对于猫的健康至关重要.
研究的目的:
- 开发和评估一种使用修饰的VP1蛋白对FCV的新型mRNA疫苗.
- 在猫模型中评估LNP-VP1-mRNA疫苗的免疫性和保护功效.
主要方法:
- 构建了一个代码子优化的VP1基因,具有特定的氨基酸删除以获得免疫性.
- 通过体外转录生成VP1-mRNA并将其封装成脂质纳米粒子 (LNP).
- 在小鼠和猫中通过主要增强免疫接种给予LNP-VP1-mRNA疫苗,随后进行FCV挑战.
主要成果:
- 在细胞中证实了FCV-VP1的成功表达,并描述了LNP疫苗配方.
- 疫苗诱导了剂量依赖的抗FCV IgG和中和抗体,以及关键的细胞因子反应 (IFN-β,IFN-γ,IL-4,IL-6).
- 在没有临床症状的接种过疫苗的猫中,实现了100%的存活率和对FCV挑战的完全保护.
结论:
- 该LNP-VP1-mRNA疫苗是预防猫的FCV感染的安全和高度有效的候选人.
- 这种mRNA疫苗平台显示出对控制猫类呼吸道疾病的重大前景.
- 进一步开发可能会导致新一代的FCV疫苗.
更多相关视频
相关概念视频
Vaccinations
51.8K
Overview
51.8K
pre-mRNA Processing
57.6K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.6K
mRNA Stability and Gene Expression
6.7K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
6.7K
Regulated mRNA Transport
7.0K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.0K
What is the Immune System?
131.2K
Overview
131.2K
Nuclear Export of mRNA
8.8K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K

